Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.68 |
| ▸ | FBP1 | P09467 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | IGF2R | P11717 | 4/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.40 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.40 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HK1 | P19367 | 1/20 | 0.40 |
| ▸ | HK2 | P52789 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29394667 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL20291477 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL14669223 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL4363197 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL20299968 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL29425232 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL25361382 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL4363206 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL20558753 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL14414833 | 0.96 | AMDHD2 (0.62) | AMDHD2FBP1MAPK1IGF2RLGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023229403-A1 | YDJC INHIBITOR SCREENING METHOD | 동국대학교 산학협력단 | 2023-11-30 | — | — | WO | claimed |
| US-12600997-B2 | Fermentative production of sialylated saccharides | CHR. HANSEN A/S (DK) | 2026-04-14 | — | — | US | disclosed |
| US-20240293555-A1 | CARBOHYDRATE CONJUGATES FOR THE DELIVERY OF THERAPEUTIC OLIGONUCLEOTIDES | CEDARS-SINAI MEDICAL CENTER | 2024-09-05 | — | — | US | disclosed |
| US-11920173-B2 | Fermentative production of N-acetylneuraminic acid | CHR HANSEN HMO GMBH (DE) | 2024-03-05 | — | — | US | disclosed |
| WO-2023229403-A1 | YDJC INHIBITOR SCREENING METHOD | 동국대학교 산학협력단 | 2023-11-30 | — | — | WO | disclosed |
| EP-3575404-B1 | FERMENTATIVE PRODUCTION OF SIALYLATED SACCHARIDES | CHR HANSEN HMO GMBH (DE) | 2022-10-19 | — | — | EP | disclosed |
| EP-3802845-A1 | FERMENTATIVE PRODUCTION OF SIALYLATED SACCHARIDES | Jennewein Biotechnologie GmbH (DE) | 2021-04-14 | — | — | EP | disclosed |
| EP-3697805-A1 | FERMENTATIVE PRODUCTION OF N-ACETYLNEURAMINIC ACID | Jennewein Biotechnologie GmbH (DE) | 2020-08-26 | — | — | EP | disclosed |
| CN-111556873-A | Fermentative production of N-acetylneuraminic acid | 詹尼温生物技术有限责任公司 | 2020-08-18 | — | — | CN | disclosed |
| WO-2019228993-A1 | FERMENTATIVE PRODUCTION OF SIALYLATED SACCHARIDES | JENNEWEIN BIOTECHNOLOGIE GMBH (DE) | 2019-12-05 | — | — | WO | disclosed |
| WO-2019076941-A1 | FERMENTATIVE PRODUCTION OF N-ACETYLNEURAMINIC ACID | JENNEWEIN BIOTECHNOLOGIE GMBH (DE) | 2019-04-25 | — | — | WO | disclosed |
| EP-3473644-A1 | FERMENTATIVE PRODUCTION OF N-ACETYLNEURAMINIC ACID | Jennewein Biotechnologie GmbH (DE) | 2019-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240293555-A1 | CARBOHYDRATE CONJUGATES FOR THE DELIVERY OF THERAPEUTIC OLIGONUCLEOTIDES | CSGALNACT1, SLC2A8, FUT6 | AMDHD2 76/4885FBP1 120/4885MAPK1 4220/4885 |
| US-12600997-B2 | Fermentative production of sialylated saccharides | RNGTT, NANS, ENGASE | AMDHD2 122/4885FBP1 30/4885MAPK1 4098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.